[{"id":"6ade3251-a0c0-420c-9933-f0b74d457b4d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04152148","created_at":"2021-01-18T20:14:56.864Z","updated_at":"2024-07-02T16:35:56.209Z","phase":"Phase 1","brief_title":"A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients","source_id_and_acronym":"NCT04152148","lead_sponsor":"Bio-Thera Solutions","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BAT4306F"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 09/04/2018","start_date":" 09/04/2018","primary_txt":" Primary completion: 01/13/2021","primary_completion_date":" 01/13/2021","study_txt":" Completion: 01/13/2021","study_completion_date":" 01/13/2021","last_update_posted":"2023-02-08"}]